Jeesa George. (2022). Pharmacovigilance During Pre-Approval Phases -Comparison of ICH E2E, CIOMS VI, FDA, EMEA/CHMP and CDSCO Risk Management Guidelines. International Journal of Progressive Research in Science and Engineering, 3(07), 80–86. Retrieved from https://journal.ijprse.com/index.php/ijprse/article/view/667